Research Updates: immune function

Below are short extracts from research updates about this subject - select more to read each item.

  1. Issue 286

    LM OLIVEIRA and COLLEAGUES,  1 Laboratory of Dermatology and Immunodeficiencies, LIM-56, Department of Dermatology, School of Medicine, University of São Paulo, Institute of Tropical Medicine of São Paulo, São Paulo, SP, Br1


  2. Issue 285

    DALL'ACQUA and COLLEAGUES, 1 Department of Pharmaceutical Sciences, University of Padova, Via F. Marzolo 5, 35131, Padova, Italy; 2 Faculty of Pharmacy, University of Ljubljana, Askerceva 7, SI-1000 Ljubljana, Slovenia; 3 National Laboratory of the 1


  3. Issue 281

    FILICE and COLLEAGUES, 1 School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada; 2 Département Anthropologie, Université Laval, Québec City, Québec, Canada; 3 Centre de recherche du 1


  4. Issue 280

    SAHEBARI and COLLEAGUES, 1 Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran conducted a study aimed to evaluate the role of selenium and autoimmune rheumatic diseases.


  5. Issue 271

    CHIANG and COLLEAGUES, 1. Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Ma1


  6. Issue 261

    GAO and COLLEAGUES,  1. Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province, 130062, People's Republic of China; 2. Department of Clinical Veterinary Medicine, College of Veter1


  7. Issue 240

    ROULEAU and COLLEAGUES,  (1)Centre hospitalier universitaire de Québec, Quebec City, Quebec, Canada investigated the incidence of anaphylaxis following AS03-adjuvanted H1N1pdm09 vaccine.


  8. Issue 237

    LI and COLLEAGUES, (1)Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, M1


  9. Issue 235

    PODER and COLLEAGUES,  (1)Tartu University Clinics Foundation, Raja 31, Tartu, Estonia. Electronic address: (2)Pediatric Department, Faculty Hospital, Trenčín University AD, Trenčín, Slovakia. (3)GlaxoSmithKline Vacci1


  10. Issue 227

    LU and COLLEAGUES, (1)Medical Statistics & Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China assessed the quality of reports and their correlates in randomized controlled trials (RCTs) of immunotherapy for Gu1


  11. Issue 222

    WANG and COLLEAGUES, (1)School of Public Health, Capital Medical University, Beijing, China ; Municipal Key Laboratory of Clinical Epidemiology, Beijing, China; School of Medical Sciences, Edith Cowan University, Perth, Australia reviewed the litera1


  12. Issue 219

    KARUSSIS and PETROU, Department of Neurology, Multiple Sclerosis Center and Laboratory of Neuroimmunology, The Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel searched the literature to quantify and 1


  13. Issue 213

    SKOPINSKA-ROZEWSKA and COLLEAGUES, Department of Pathology, Biostructure Center, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland.  evaluated the in vivo ef1


  14. Issue 212

    SUNG-HEE and COLLEAGUES, Geranti Pharm Ltd., Dep’t of Food Science and Technology, Chung-Ang Univ., Dept of Nutrition and Culinary Science, Hankyung National Univ. Soonchunhyang Univ. Hospital, Korea investigated the effect of germanium-fortif1


  15. Issue 204

    CASSANO and COLLEAGUES, Second Dermatology Clinic, University of Bari, Bari, Italy.  studied the effect of oral supplementation (OS) with a nutraceutical, containing1


  16. Issue 204

    CONSTANTINI and COLLEAGUES, Hadassah Optimal Sport Medicine Center, Department of Orthopedic Surgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. conducted a study to det1


  17. Issue 204

    PETERSEN and COLLEAGUES, Scientific Department, Polichem SA, Lugano, Switzerland conducted a randomized, double blind, parallel groups, placebo controlled clinical trial to assess the efficacy and safety profile of 250 mg ascorbic acid (Vit. C, V1


  18. Issue 202

    DURAMAD and HOLLAND, Genentech Inc, 1 DNA Way MS #59, South San Francisco, CA 94080, USA. review, discuss and provide examples of how the identification and development of immunol1


  19. Issue 201

    GOLDSON and COLLEAGUES, Institute of Food Research, Norwich Research Park, Norwich, UK studied the effect of different doses and forms of Se on gene expression of selenoprotein S (SEPS1), selenoprotein W (SEPW1) and selenoprotein R (SEPR), and respo1


  20. Issue 182

    MARKO and COLLEAGUES, Nutritional Immunology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA evaluated the effect of in vitro supplementation with vitamin E upon T cell signall1


« Prev 1 2

ICAN Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

Cycle from Milan to Venice for Regain 2023

top of the page